Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

Presenting new clinical data from Phase 1/2 multi-center clinical trial of LYL314, a next-generation dual-targeting CD19/CD20 CAR T-cell product candidate for the treatment of relapsed and/or refracto ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical stage biotechnology company dedicated to pioneering innovative cancer and ...

When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to treatment for some patients, with its high end durable response rates, and ...

Fiorina and colleagues demonstrated that the pharmacological blockade of TMEM219 signal through a recombinant protein based on the extracellular portion of the TMEM219 receptor is able to preserve ...

The existence of specialised structures that allow a continuous exchange of CSF between different anatomical compartments at ...

Close to 200 people marched in homage to missing and murdered Indigenous women, girls and two-spirited people in Hay River on May 5. A sea of red progressed through the town as residents took to ...

The US regulator has approved Aucatzyl (obecabtagene autoleucel or obe-cel) for the treatment of adults with relapsed or refractory B-cell precursor ALL based on the results of the phase 2 FELIX ...

Genetic studies can offer powerful insights for the development of disease-modifying therapies for Alzheimer's disease.

Equus How did horses become some of the greatest athletes in the animal kingdom? Researchers at Johns Hopkins Medicine have pinpointed a genetic mutation and evolutionary process that occurred ...